A Double-Blind, Randomized, Placebo-Controlled Phase 3 Study of Orally administered PLX3397 in Subjects with Pigmented Villonodular Synovitis or Giant Cell Tumor of the Tendon Sheath
Administered By
Awarded By
Contributors
- Riedel, Richard Francis Principal Investigator
Start/End
- August 1, 2015 - July 31, 2021